-
1 Comment
Fiji Kava Limited is currently in a long term downtrend where the price is trading 23.0% below its 200 day moving average.
From a valuation standpoint, the stock is 94.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.1.
Fiji Kava Limited's total revenue rose by 111.7% to $496K since the same quarter in the previous year.
Its net income has increased by 25.9% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 2.2% to $-1M since the same quarter in the previous year.
Based on the above factors, Fiji Kava Limited gets an overall score of 4/5.
Exchange | AU |
---|---|
CurrencyCode | AUD |
Sector | Healthcare |
Industry | Pharmaceuticals |
ISIN | AU0000028359 |
Market Cap | 1M |
---|---|
PE Ratio | None |
Target Price | None |
Dividend Yield | 0.0% |
Beta | 1.15 |
Fiji Kava Limited operates as a medicinal kava health and wellness company in Australia, New Zealand, Fiji, and the United States. It produces and sells noble kava extract capsules, and powder mixes under the Fiji Kava and Taki Mai brand names. The company also sells its products through fijikava.com. Fiji Kava Limited was incorporated in 2014 and is based in West End, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FIJ.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025